Musaffa Logo
Anatara Lifesciences Ltd ANR.AX

Last Updated: Jul 16, 12:00 AM·ASX

ANR.AX Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Anatara Lifesciences Ltd is classified as halal.

HALAL

Report Source: 2025 2nd Quarter Report

Anatara Lifesciences Ltd

Anatara Lifesciences Ltd. Stock Analysis ANR.AX

Australia Health Care Nano Cap Report:
Anatara Lifesciences Ltd. engages in the development of non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. The company is headquartered in Adelaide, South Australia. The company went IPO on 2014-10-16. The firm is engaged in developing evidence-based solutions for gastrointestinal diseases in humans and animals. Its products include Gastrointestinal ReProgramming (GaRP), Detach, BONIFF, and ANR-pf. Its GaRP Product is a microbiome-targeted multi-component complementary medicine, which is designed to address the primary underlying factors associated with chronic gastrointestinal conditions, such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Detach is a non-antibiotic approach to aid in the control of diarrheal disease known as scour, which is developed using bromelain. BONIFF is a revised formulation which is applied to dry feed for piglets after weaning, reducing labor input, and simplifying the entire process. ANR-pf is an enriched formulation for poultry in water, designed to allow the full delivery of key additives in a quick and flexible dosing method.
Read More

Anatara Lifesciences Ltd (ANR.AX) Chart

Key Statistics of Anatara Lifesciences Ltd (ANR.AX)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

AUD0.01AUD0.01

Today's Open

AUD0.01

Volume

5436.00

P/E Ratio (TTM)

-

52 Week Range

AUD0.01AUD0.02

Market Cap

3.16M

Avg. Volume

537.35K

Dividend Yield

-

Financial Metrics & Statements of Anatara Lifesciences Ltd (ANR.AX)

Super Investors Invested in Anatara Lifesciences Ltd (ANR.AX)

FAQ's for Anatara Lifesciences Ltd (ANR.AX)

  • As of July 2026, Anatara Lifesciences Ltd ANR.AX is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Anatara Lifesciences Ltd using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Anatara Lifesciences Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Anatara Lifesciences Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Anatara Lifesciences Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Anatara Lifesciences Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.